As of 2025-09-17, the Relative Valuation of Amphastar Pharmaceuticals Inc (AMPH) is 70.68 USD. This relative valuation is based on P/E multiples. With the latest stock price at 27.00 USD, the upside of Amphastar Pharmaceuticals Inc based on Relative Valuation is 161.8%.
The range of the Relative Valuation is 26.07 - 104.48 USD.
| Range | Selected | |
| Trailing P/E multiples | 9.0x - 32.8x | 20.4x |
| Forward P/E multiples | 18.4x - 33.0x | 26.0x |
| Fair Price | 26.07 - 104.48 | 70.68 |
| Upside | -3.4% - 286.9% | 161.8% |
| Date | P/E |
| 2025-09-17 | 9.50 |
| 2025-09-16 | 9.32 |
| 2025-09-15 | 9.41 |
| 2025-09-12 | 9.69 |
| 2025-09-11 | 9.90 |
| 2025-09-10 | 9.80 |
| 2025-09-09 | 10.12 |
| 2025-09-08 | 10.10 |
| 2025-09-05 | 10.16 |
| 2025-09-04 | 10.08 |
| 2025-09-03 | 10.15 |
| 2025-09-02 | 10.64 |
| 2025-08-29 | 10.57 |
| 2025-08-28 | 10.45 |
| 2025-08-27 | 10.52 |
| 2025-08-26 | 10.47 |
| 2025-08-25 | 10.30 |
| 2025-08-22 | 10.53 |
| 2025-08-21 | 10.24 |
| 2025-08-20 | 10.22 |
| 2025-08-19 | 10.47 |
| 2025-08-18 | 10.27 |
| 2025-08-15 | 10.30 |
| 2025-08-14 | 10.43 |
| 2025-08-13 | 10.52 |
| 2025-08-12 | 10.48 |
| 2025-08-11 | 9.44 |
| 2025-08-08 | 8.22 |
| 2025-08-07 | 7.46 |
| 2025-08-06 | 7.19 |
| 2025-08-05 | 7.40 |
| 2025-08-04 | 7.39 |
| 2025-08-01 | 7.32 |
| 2025-07-31 | 7.23 |
| 2025-07-30 | 7.37 |
| 2025-07-29 | 7.48 |
| 2025-07-28 | 7.68 |
| 2025-07-25 | 7.72 |
| 2025-07-24 | 7.77 |
| 2025-07-23 | 7.81 |
| 2025-07-22 | 7.37 |
| 2025-07-21 | 7.31 |
| 2025-07-18 | 7.12 |
| 2025-07-17 | 7.49 |
| 2025-07-16 | 7.34 |
| 2025-07-15 | 7.31 |
| 2025-07-14 | 7.58 |
| 2025-07-11 | 7.48 |
| 2025-07-10 | 7.67 |
| 2025-07-09 | 7.75 |